Log in with Facebook 
Food and Drug Administration (FDA) has provided a new type of study design for conducting Phase I first-in-human oncology studies. This design, known as a multiple expansion cohort (MEC) design, allows the sponsor to have multiple experimental groups in a single study simultaneously. Read More
